Cochlear Aktie
159,72EUR | -23,10EUR | -12,64% |
WKN: 898321 / ISIN: AU000000COH5
Personal
2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|
Personal am Ende des Jahres | 4 000 | 4 000 | 4 500 | 4 800 | 5 000 |
Umsatz pro Mitarbeiter in Mio. EUR | 0,34 | 0,37 | 0,36 | 0,41 | 0,45 |
Bilanz (in Mio. AUD) - Aktiva
2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|
Summe Umlaufvermögen | 1 478 | 1 230 | 1 327 | 1 362 | 1 452 |
Summe Anlagevermögen | 1 106 | 1 208 | 1 138 | 1 207 | 1 293 |
Summe Aktiva | 2 583 | 2 438 | 2 465 | 2 569 | 2 745 |
Bilanz (in Mio. AUD) - Passiva
2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|
Summe Fremdkapital | 1 182 | 737 | 779 | 820 | 905 |
Summe Eigenkapital | 1 402 | 1 702 | 1 686 | 1 749 | 1 841 |
Summe Passiva | 2 583 | 2 438 | 2 465 | 2 569 | 2 745 |
Adresse
1 University Avenue, 2109 Sydney | |
Telefon | +61 (2) 9428-6555 |
Fax | +61 (2) 9428-6353 |
Internet | http://www.cochlear.com/ |
Management
Brian Kaplan
Senior VP-Global Clinical Strategy & Innovation |
Bruce G. Robinson
Independent Non-Executive Director |
Caroline Clarke
Non-Executive Director |
Catriona Alison Deans
Chairman |
Christine Frances McLoughlin
Independent Non-Executive Director |
Dean Phizacklea
Senior Vice President-Global Marketing |
Diggory William Howitt
President, CEO, Executive Director & MD |
Glen Francis Boreham
Independent Non-Executive Director |
Jan Janssen
Chief Technology Officer |
Jennifer Hornery
Senior Vice President-People & Culture |
Karen Lee Collett Penrose
Independent Non-Executive Director |
Karen O’Driscoll
Chief Information Officer |
Kristina Devon
Vice President-Investor Relations & Sustainability |
Kristy Jo
Co-Secretary |
Lisa Aubert
President-North America |
Michael Grenfell Daniell
Independent Non-Executive Director |
Michael del Prado
Independent Non-Executive Director |
Rob McGrory
Co-Secretary |
Sarah Thom
Chief Financial Officer |
Stuart Sayers
President-Asia Pacific & Latin America |